Viewing Study NCT03167957

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-02-20 @ 8:08 PM
Study NCT ID: NCT03167957
Status: WITHDRAWN
Last Update Posted: 2019-03-08
First Post: 2017-05-23
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis
Sponsor: Matinas BioPharma Nanotechnologies, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Vulvovaginal Candidiases View
None Yeast Infection View
None Vulvovaginitis View
None Yeast Infection Vaginal View
None Candidiasis, Vulvovaginal View
Keywords:

Keywords

Keyword Brief Keyword Text View
None fluconazole View
None fluconazole-resistant View